In a recent study presented at the AHA’s Scientific Sessions, researchers examined the primary outcomes of number of deaths, adverse events, time to the first heart failure event, or a KCCQ score that had...
In a recent study presented at the AHA’s Scientific Sessions, researchers examined the primary outcomes of number of deaths, adverse events, time to the first heart failure event, or a KCCQ score that had...
Since the optimal duration of dual antiplatelet therapy remains uncertain, researchers of a recent study examined a 1-month course of DAPT compared with 6 to 12-months of therapy following...
This direct-acting oral anticoagulant may be superior to the current standard of care anticoagulant for patients with a bioprosthetic mitral valve. In a study presented at AHA Scientific Sessions 2020,...
A reduction in cardiovascular events may be possible with the use of a new combination pill of blood-pressure- and cholesterol-lowering medications. In this trial, the researchers examined how this...
The researchers assessed the association between heart failure status at presentation for ACS and future ischemic events, rehospitalization for heart failure, and death 1 year after discharge from the...
To determine the cardiovascular outcomes of patients with a history of AFib who were admitted to the hospital with confirmed COVID-19 infection, researchers stratified patients by history of AFib and...
To test whether low stroke-volume reserve during exercise would accompany greater impairment in dynamic starling mechanism gain in patients with HFpEF, researchers studied 11 such patients at rest and...
In a recent study, researchers tested the potential relationship between coffee consumption and the risks for heart failure and stroke via machine learning.
